Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

17

Revenue 2017

Stelara

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Stelara was produced by Johnson & Johnson.

Janssen’s Stelara approved by FDA for psoriatic arthritis in paediatric patients

Janssen’s Stelara approved by FDA for psoriatic arthritis in paediatric patients

Janssen – a pharmaceutical arm of Johnson &Johnson – has announced that Stelara (ustekinumab) has been approved by the US Food and Drug Administration (FDA) for the treatment of paediatric patients aged six ... The approval was based on data of the

Amgen’s biosimilar delivers impressive phase 3 results for psoriasis compared to Janssen’s Stelara

Amgen’s biosimilar delivers impressive phase 3 results for psoriasis compared to Janssen’s Stelara Amgen has announced preliminary results from a phase 3 study evaluating the efficacy and safety of its drug candidate ABP 654 compared to Janssen’s Stelara in adult patients with moderate ... The study evaluated the percentage improvement from baseline

J&J inks $6.5bn all-cash deal to acquire Momenta

J&J inks $6.5bn all-cash deal to acquire Momenta J&J already has high stakes in the autoimmune disease market, with some of its existing products, including psoriasis med Stelara (ustekinumab), already reaching blockbuster status.

J&J splashes $750m on anti-inflammatory drug bermekimab

J&J splashes $750m on anti-inflammatory drug bermekimab J&J already has high stakes in the anti-inflammatory market, with its blockbuster IL-12/IL-23 inhibitor blockbuster Stelara (ustekinumab) and follow-up Tremfya (guselkumab). ... The therapy is a follow-up to its older blockbuster Stelara, which is facing

UCB’s bimekizumab beats AbbVie’s Humira in phase 3 trial

UCB’s bimekizumab beats AbbVie’s Humira in phase 3 trial This includes a recent phase 3 BE VIVID study comparing the drug to Johnson &Johnson’s Stelara (ustekinumab), which bimekizumab also demonstrated superiority over.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
11 London

We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our...

Latest intelligence

Animation: Living With
The journey from the patient's perspective...
Danny Buckland July2022
Achieving communication excellence by targeting the right channel at the right time
By Danny Buckland...
6 trends shaping the future of personalized medicine
Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators....